EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tobacco and cannabis use among pregnant women with prenatal opioid use

E Melinda Mahabee-Gittens, Nicole Mack, Carla M Bann, Jamie E Newman, Junfang Zhao, Kenneth D R Setchell, Lara Stone, Namasivayam Ambalavanan, Myriam Peralta-Carcelen, Sara B DeMauro, Scott A Lorch, Deanne E Wilson-Costello und 4 weitere

Addictive Behaviors · 2025-11 · 170 · 108442

DOI: 10.1016/j.addbeh.2025.108442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addictive Behaviors, 2025-11. Verfasst von E Melinda Mahabee-Gittens und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Department of Pediatrics, University of Cincinnati, College of Medicine, Ci…. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Pregnancy Complications, Marijuana Use, Tobacco Use. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIEHS NIH HHS, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There is a paucity of information on tobacco and cannabis use patterns in pregnant women who use opioids. Our objective was to examine sociodemographic, tobacco, and cannabis use patterns during pregnancy among pregnant women with opioid use. METHODS: We recruited 206 pregnant women with biochemically verified opioid use during pregnancy, of whom 98 self-reported taking only medications for opioid use disorder (MOUD) and 108 reported taking other opioids during pregnancy. We examined sociodemographic characteristics and self-report of tobacco and cannabis use overall and by trimester. Chi-square and t-tests were used to assess differences between the MOUD-only vs other opioids groups. Logistic regression models were used to examine differences in factors associated with tobacco and cannabis use. RESULTS: Mean (SD) age was 30.7 years (4.6); 81.9 % were non-Hispanic White, and 92.6 % had public insurance. Of the 91 women taking MOUD only and completing the substance use self-report, 50 (54.9 %) reported tobacco use only, 3 (3.3 %) reported cannabis use only, and 24 (26.4 %) reported both tobacco and cannabis use. Tobacco and cannabis use was similar for women taking other opioids (p = 0.98). Adjusted odds ratios indicated that there was consistent use of all tobacco products (p = 0.28) including e-cigarette products (p = 0.18) throughout all 3 trimesters of pregnancy. There was decreased use of cannabis over the course of pregnancy with 29.8 % using cannabis during the first trimester and 16.5 % during the last trimester (p = 0.0003). CONCLUSIONS: While we observed no differences in tobacco and cannabis use between those taking MOUD only versus other opioids, we observed high rates of tobacco and cannabis use among pregnant women with opioid use. These findings underscore the need for tobacco and cannabis use education and cessation interventions throughout pregnancy for those with OUD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersPregnancy ComplicationsMarijuana UseTobacco UseHumansFemalePregnancyAdultYoung AdultPregnant PeopleAnalgesics, OpioidSelf Report

Stichwörter der Autor:innen

CannabisElectronic cigarettesOpioid use disorderPregnancySubstance use disorderTobacco

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA. Electronic address: melinda.mahabee-gittens@c…
  • Analytics Division, RTI International, Research Triangle Park, NC 27709, USA.
  • Division of Pathology & Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH 45229, USA; Division of Pathology & Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Division of Neonatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Förderung

  • NICHD NIH HHS
  • NIEHS NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institute of Child Health and Human Development

Zitieren

APA

Mahabee-Gittens, E. M., Mack, N., Bann, C. M., Newman, J. E., Zhao, J., Setchell, K. D. R., Stone, L., Ambalavanan, N., Peralta-Carcelen, M., DeMauro, S. B., Lorch, S. A., Wilson-Costello, D. E., Poindexter, B. B., Limperopoulos, C., Davis, J. M., & Merhar, S. L. (2025). Tobacco and cannabis use among pregnant women with prenatal opioid use. Addictive Behaviors, 170, 108442. https://doi.org/10.1016/j.addbeh.2025.108442

Vancouver

Mahabee-Gittens EM, Mack N, Bann CM, Newman JE, Zhao J, Setchell KDR, et al. Tobacco and cannabis use among pregnant women with prenatal opioid use. Addictive Behaviors. 2025;170:108442. doi:10.1016/j.addbeh.2025.108442

BibTeX
@article{MahabeeGittens2025,
  author = {Mahabee-Gittens, E Melinda and Mack, Nicole and Bann, Carla M and Newman, Jamie E and Zhao, Junfang and Setchell, Kenneth D R and Stone, Lara and Ambalavanan, Namasivayam and Peralta-Carcelen, Myriam and DeMauro, Sara B and Lorch, Scott A and Wilson-Costello, Deanne E and Poindexter, Brenda B and Limperopoulos, Catherine and Davis, Jonathan M and Merhar, Stephanie L},
  title = {Tobacco and cannabis use among pregnant women with prenatal opioid use},
  journal = {Addictive Behaviors},
  year = {2025},
  volume = {170},
  pages = {108442},
  doi = {10.1016/j.addbeh.2025.108442}
}
Kostenlos starten →